Skip to content

Effects of probiotics combined with milk powder supplemented with lactopontin on immunity and gastrointestinal function of infants: a prospective randomized controlled study

Effects of probiotics combined with milk powder supplemented with lactopontin on immunity and gastrointestinal function of infants: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061923
Enrollment
Unknown
Registered
2022-07-11
Start date
2022-07-09
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant immunity and gastrointestinal function

Interventions

Group 1 :artificially fed and fed synbiotics combined with lactobridgetin combined with synbiotics infant formula milk powder
Group 2:artificially fed with synbiotics and synbiotics infant formula without lactopontin
Group 3:artificially fed, fed with lactophysin added syngenicity infant formula and did not use probiotics
Group 4:exclusive breastfeeding

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Infants from 2 to 9 months; 2. Full-term infants, 37 weeks = 2500 grams, <= 4000 grams; 4. Single birth; 5. Babies with normal pregnancy and vaginal delivery; 6. Have not used food or drugs that affect intestinal flora and metabolites within 1 month, mainly including probiotics, infant formula supplemented with lactopontin, and antibiotics.

Exclusion criteria

Exclusion criteria: 1. Patients with diseases requiring mechanical ventilation or drug treatment within one week after birth (excluding infantile jaundice patients treated with blue light); 2. Children with serious diseases such as heart, liver, kidney, hematopoietic system or metabolic genetics; 3. Those who affect feeding or metabolism due to body defects; 4. Patients with milk allergy.

Design outcomes

Primary

MeasureTime frame
Stool routine;Fecal intestinal flora detection;Determination of fecal short-chain fatty acids;fecal secretory immunoglobulin A;Urine routine;Blood routine;Lymphocyte subgroup;Cell factor;Height;Weight;Head circumference;Upper arm circumference;Incidence of infectious diseases;Occurrence of gastrointestinal events;Allergic condition;

Countries

China

Contacts

Public ContactYe Yanbin

The First Affiliated Hospital of Sun Yat-sen University

yeyanbin@mail.sysu.edu.cn+86 13533987613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026